ABBV - AbbVie Inc.
233.86
-0.400 -0.171%
Share volume: 6,548,207
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$234.26
-0.40
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-03-2024 | 08-07-2024 | 11-04-2024 | 02-14-2025 | 05-09-2025 | 08-04-2025 | 11-04-2025 | 02-20-2026 | |
| Total revenue | 12.310 B | 14.462 B | 14.460 B | 15.102 B | 13.343 B | 15.423 B | 15.776 B | 16.618 B | |
| Cost of revenue | 4.258 B | 5.139 B | 4.212 B | 3.295 B | 4.250 B | 4.346 B | 7.984 B | 6.640 B | |
| Gross profit | 8.052 B | 9.323 B | 10.248 B | 11.807 B | 9.093 B | 11.077 B | 7.792 B | 9.978 B | |
| 15.78% | 9.92% | 15.21% | -22.99% | 21.82% | -29.66% | 28.05% | |||
| Operating expenses | 5.254 B | 5.325 B | 6.417 B | 13.304 B | 5.360 B | 6.207 B | 5.888 B | 5.651 B | |
| Selling general and admin | 3.315 B | 3.377 B | 4.287 B | 6.530 B | 3.293 B | 4.076 B | 3.569 B | 3.072 B | |
| Research and development | 1.939 B | 1.948 B | 2.130 B | 6.774 B | 2.067 B | 2.131 B | 2.319 B | 2.579 B | |
| Total expenses | 5.254 B | 5.325 B | 6.417 B | 13.297 B | 5.360 B | 6.183 B | 5.888 B | 5.434 B | |
| 1.35% | 20.51% | 107.22% | -59.69% | 15.35% | -4.77% | -7.71% | |||
| Operating income | 2.798 B | 3.998 B | 3.831 B | -1.490 B | 3.733 B | 4.894 B | 1.904 B | 4.544 B | |
| Ebit | 2.208 B | 2.652 B | 2.675 B | -1.659 B | 2.288 B | 2.232 B | 1.381 B | 3.323 B | |
| Pretax income | 1.755 B | 2.146 B | 2.084 B | -2.269 B | 1.661 B | 1.554 B | 714.000 M | 2.668 B | |
| 22.28% | -2.89% | -208.88% | -173.20% | -6.44% | -54.05% | 273.67% | |||
| Income tax | 383.000 M | 773.000 M | 520.000 M | -2.246 B | 372.000 M | 613.000 M | 526.000 M | 853.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.372 B | 1.373 B | 1.564 B | -23.000 M | 1.289 B | 941.000 M | 188.000 M | 1.815 B | |
| 0.07% | 13.91% | -101.47% | 5,704.35% | -27.00% | -80.02% | 865.43% |